Nurix Therapeutics, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Nurix Therapeutics, Inc.
- Company name
- Nurix Therapeutics, Inc.
- Organisation type
- Industry
- Registered legal name
- Nurix Therapeutics, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001549595
Related records
Trials (10)
- A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
- A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
- A Study of DeTIL-0255 in Adults With Advanced Malignancies
- A Study of NX-1607 in Adults With Advanced Malignancies
- A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
- Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL